FDA Approved: APTIOM — Supplemental Application (Sumitomo Pharma America, Inc.)

View source ↗

Summary

FDA has approved a Supplemental Application for APTIOM (eslicarbazepine acetate) from Sumitomo Pharma America, expanding labeling/indications for the anticonvul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• APTIOM (Eslicarbazepine acetate)

Snippet

SUPPL AP for APTIOM (ESLICARBAZEPINE ACETATE)